CIK 0001712762
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465211056
- Phone
- +1 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- 4 Conversion Director acquired 40,907 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Secretary, EVP, Gen. Counsel acquired 3,619 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,163 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 4,081 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 4,081 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 2,448 shares
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Chief Sci. & Med. Officer acquired 7,239 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President, CEO bought 16,326 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Executive Chairman bought 40,916 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 16,326 shares
- 3 Insider Initial Statement of Ownership
Page 4 of 4 · 80 filings